MARKET

IONS

IONS

Ionis Pharmaceuticals
NASDAQ
72.15
-2.09
-2.82%
After Hours: 72.15 0 0.00% 16:34 03/27 EDT
OPEN
74.00
PREV CLOSE
74.24
HIGH
74.05
LOW
71.87
VOLUME
1.95M
TURNOVER
--
52 WEEK HIGH
86.74
52 WEEK LOW
23.95
MARKET CAP
11.92B
P/E (TTM)
-30.2706
1D
5D
1M
3M
1Y
5Y
1D
Is It Time To Reassess Ionis Pharmaceuticals (IONS) After Its Strong One Year Share Price Run?
Simply Wall St · 2h ago
GSK: European Medicines Agency To Review MAA For Bepirovirsen
NASDAQ · 12h ago
Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market
Benzinga · 1d ago
Arrowhead price target lowered to $81 from $84 at BofA
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Ionis Pharmaceuticals (IONS)
TipRanks · 1d ago
Ionis Pharmaceuticals Is Maintained at Overweight by Barclays
Dow Jones · 1d ago
Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $106
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Ionis Pharmaceuticals (IONS)
TipRanks · 1d ago
More
About IONS
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults. SPINRAZA is used for the treatment of pediatric and adult patients with spinal muscular atrophy. QALSODY is approved for the treatment of Amyotrophic Lateral Sclerosis in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene, or SOD1-ALS. TEGSEDI is approved for the treatment of ATTRv-PN in adults. WAYLIVRA is approved as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk of acute, potentially fatal pancreatitis.

Webull offers Ionis Pharmaceuticals Inc stock information, including NASDAQ: IONS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IONS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IONS stock methods without spending real money on the virtual paper trading platform.